<code id='757B945EDC'></code><style id='757B945EDC'></style>
    • <acronym id='757B945EDC'></acronym>
      <center id='757B945EDC'><center id='757B945EDC'><tfoot id='757B945EDC'></tfoot></center><abbr id='757B945EDC'><dir id='757B945EDC'><tfoot id='757B945EDC'></tfoot><noframes id='757B945EDC'>

    • <optgroup id='757B945EDC'><strike id='757B945EDC'><sup id='757B945EDC'></sup></strike><code id='757B945EDC'></code></optgroup>
        1. <b id='757B945EDC'><label id='757B945EDC'><select id='757B945EDC'><dt id='757B945EDC'><span id='757B945EDC'></span></dt></select></label></b><u id='757B945EDC'></u>
          <i id='757B945EDC'><strike id='757B945EDC'><tt id='757B945EDC'><pre id='757B945EDC'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:127
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          Bulgari apologizes to China for listing Taiwan as a country after online backlash
          Bulgari apologizes to China for listing Taiwan as a country after online backlash

          1:28AwomanwalksbytheBulgaristoreatahigh-endshoppingmallinBeijing,Wednesday,July12,2023.Italianluxury

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Yancopoulos of Regeneron works to expand Dupixent success

          GeorgeYancopoulosonthe2024BreakthroughSummitEaststageSTATGeorgeYancopoulosisintouchwithhisteenagesel